ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Xiangjun Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6519-7893; OpenAlex author ID A5115601882. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2025: 2 papers

Papers 2

Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target. Co-author DOI 10.3389/fimmu.2025.1708441 ↗
SUMOylation substrate encoding genes as prognostic biomarkers in pancreatic ductal adenocarcinoma with functional assessment of SAF-B2. Co-author DOI 10.3389/fphar.2025.1532658 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jian Wang · 1 shared paper, 2025 · strength 0.37
- Paper SUMOylation substrate encoding genes as prognostic biomarkers in pancreatic ductal adenocarcinoma with functional asses… DOI 10.3389/fphar.2025.1532658 ↗
Puxiongzhi Wang · 1 shared paper, 2025 · strength 0.26
- Paper Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 a… DOI 10.3389/fimmu.2025.1708441 ↗
Jian Wang · 1 shared paper, 2025 · strength 0.26
- Paper Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 a… DOI 10.3389/fimmu.2025.1708441 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.